Date: 06 Apr 2013

Influence of androgen deprivation therapy on choline PET/CT in recurrent prostate cancer

Rent the article at a discount

Rent now

* Final gross prices may vary according to local VAT.

Get Access

Abstract

Purpose

Recurrent prostate cancer is usually treated by combining radiotherapy and androgen deprivation therapy. To stage the cancer, choline positron emission tomography (PET)/CT can be performed. It is generally thought that androgen deprivation therapy does not influence choline PET/CT. In this article we focus on the molecular backgrounds of choline and androgens, and the results of preclinical and clinical studies performed using PET/CT.

Methods

Using PubMed, we looked for the relevant articles about androgen deprivation therapy and choline PET/CT.

Results

During ADT, a tendency of decreased uptake of choline in prostate cancer was observed, in particular in hormone-naïve patients.

Conclusion

We conclude that in order to prevent false-negative choline PET/CT scans androgen deprivation should be withheld prior to scanning, especially in hormone-naïve patients.